MAC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Macerich Co (MAC) does not present a strong buy opportunity for a beginner investor with a long-term strategy. The lack of positive financial performance, neutral trading sentiment, and absence of strong proprietary trading signals suggest holding off on investment at this time.
The MACD histogram is negative (-0.0475) and contracting, indicating weak momentum. RSI is neutral at 58.567, and moving averages are converging, showing no clear trend. The stock is trading near resistance levels (R1: 19.129, R2: 19.42), which may limit immediate upside potential.
KeyBanc's upgrade to Overweight with a $25 price target highlights optimism about the company's multi-year 'Path Forward Plan' and improving fundamentals. Analysts from Citi and Mizuho also raised price targets, showing some confidence in the stock's potential.
The company's financial performance in Q4 2025 was poor, with revenue, net income, EPS, and gross margin all declining significantly YoY. Analysts from JPMorgan and Goldman Sachs maintain Underweight and Sell ratings, respectively, reflecting skepticism about the stock's prospects. Additionally, no recent news or significant insider/hedge fund activity supports a bullish case.
In Q4 2025, Macerich reported a revenue decline of -4.37% YoY to $261.7M. Net income dropped by -91.04% YoY to -$18.95M, and EPS fell by -92.13% YoY to -$0.07. Gross margin also decreased by -10.72% YoY to 22.57%. These figures indicate significant financial struggles.
Analyst sentiment is mixed. While KeyBanc upgraded the stock to Overweight with a $25 price target, other analysts like JPMorgan and Goldman Sachs maintain bearish views with Underweight and Sell ratings. The price targets range from $17 to $25, reflecting uncertainty about the stock's future performance.
